Team (TISI) Q1 2025 Earnings Call Transcript

Company completed a March 2025 refinancing that lowered blended interest rate by >100 bps and extended term loan maturities to 2030 (new $175M first-lien term loan + $50M delayed draw; ~$158M of outstanding debt repaid; remaining prior term loan rolled into $97.4M second-lien due 2030). Q1 revenue was essentially flat YoY; adjusted EBITDA was $5.3M (IHT segment adjusted EBITDA +39% YoY driven by heat treating +22% and Cincinnati lab +64%), gross margin 23.8%, and adjusted net loss $14.9M. Management targets at least 15% YoY growth in adjusted EBITDA and an adjusted EBITDA margin of at least 10%, and initiated cost-savings actions expected to yield approximately $10M of annualized savings (full impact in 2026).

Analysis

The refinancing and cost program materially reshapes optionality: with lower ongoing interest drag and a multiyear maturity wall, operating cash flow becomes the marginal lever for deleveraging rather than near-term asset sales. That changes who can compete — asset-light, higher-margin inspection & testing franchises can reinvest and take share while heavy-field, capex-intense mechanical competitors are likely to see compressing returns on incremental projects. Labs and specialized heat‑treat capabilities act like annuitized margin: once utilization creeps up they convert revenue to cash far faster than project-based turnaround work, so a sustainable shift in mix would re-rate multiples toward specialized industrial services peers.

Catalysts are well-sequenced: near-term confirmation will come from a rebound in field callouts and project starts in the next 1–3 quarters; medium-term proofs are realized cost savings and Canadian turnaround over 6–18 months. Key tail risks include a tariff shock or a delayed recovery in industrial capex that re-pushes backlog and cash conversion into future periods, and the structural overhang of subordinated claims — second‑lien exposure will keep refinancing optionality more expensive until leverage demonstrably declines. Watch interest-rate volatility and overall HY spread behavior as an amplifying channel — a spike in credit spreads can wipe most of the benefit from the refinancing even if operations improve.

The market appears to underprice two non-obvious outcomes: (1) a meaningful margin re-rating if higher‑margin lab/heat‑treat utilization sustains above cyclical averages, and (2) asymmetric downside from capital-structure stigma — the latter keeps equity beta elevated and creates a favorable asymmetric return for defined‑risk option structures. Practically, trade selection should play for a 6–18 month window tied to Q2 operational confirmation and staged realization of the announced cost program, with hedges sized to protect against tariff-driven demand shocks or a one‑quarter revenue miss.

Key Decisions for Investors

• Directional equity (TISI) — Buy the stock on a Q2 print that confirms sequential improvement in field activity; 6–12 month horizon. Risk: operational miss or tariff shock; Reward: 30–80% upside if mix shift and cost saves are realized. Use a 12–16% position-level stop or size to 2–4% of equity portfolio.
• Defined‑risk call spread (TISI) — Enter a 9–12 month bull call spread roughly ATM to 20% OTM to cap premium while capturing re-rating if EBITDA progression continues; target 2–3x return on premium if guidance execution sustains. Max loss = premium; we size to limit to single-digit basis points of fund AUM.
• Protective hedge — Buy 3–6 month puts (or put spread) equal to ~30–40% of long exposure to cover tariff or backwardation risks around macro headlines; roll if volatility subsides after two consecutive improving quarters. Cost is insurance against a high‑impact downside event that would reprice subordinated credit risk.
• Credit relative (private/high‑yield) — If second‑lien paper or bonds trade materially wide to comparable small-cap industrials, consider buying senior secured paper or bonds vs. shorting unsecured HY peers to capture spread compression as leverage falls; horizon 12–24 months. Risk: protracted weak demand that prevents deleveraging; reward: 200–400bps spread compression potential priced into returns.